Activity value 75india Supplier,Last transaction date:
2025-12-05
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for omicron pharma from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 57 transactions, with a transaction quantity of 62850.1 and a transaction weight of 0.
3jal pharma corp.
yemenbuyer,they trade on 2019-09-10
1210.43%
>
4jal pharma
yemenbuyer,they trade on 2019-09-10
1210.43%
>
5green orient ltd.
hong kongsupplier,they trade on 2022-01-28
108.7%
>
+View All
Products
Total 90
ProductsTransactionsPerDetail
bat 1816.36%>
work 1614.55%>
chocolate 1412.73%>
promotional material 1210.91%>
creatine 109.09%>
+View All
Hscode rank
Total 21
HSCode NameTransactionsPerDetail
HS 210690995348.18%>
HS 210610003128.18%>
HS 30049099109.09%>
HS 6109909054.55%>
HS 4911999032.73%>
+View All
Trading Area
Total 11
AreaTransactionsPerDetail
mauritius13951.87%>
yemen4014.93%>
somalia248.96%>
thailand176.34%>
burma155.6%>
+View All
Port statistics
Total 16
Port NameTransactionsPerDetail
mundra3513.06%>
ahmedabad icd259.33%>
bombay air186.72%>
nhava sheva sea165.97%>
jnpt/ nhava sheva sea155.6%>
+View All
omicron pharma is india Supplier,
and primarily engages in the import and export business of products such as bat,work,chocolate.
According to the 52wmb.com global trade database, as of 2025-12-05, the company has completed 268 international trades,
with its main trading regions covering mauritius,yemen,somalia etc.
The core products include HS21069099,HS21061000,HS30049099 etc,
often transported via mundra,port ahmedabad icd, port bombay air etc,
and its main trading partners are all med distributors,.khalid bin walid pharmaceutical,jal pharma corp..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on omicron pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.